3646 results for «597»

Filter By

3646 results

Case-based challenging TAVI

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations. 

Case-based challenging TAVI

Tailoring mitral repair and optimising clinical outcomes using MitraClip G4

27 Sep 2021 – From PCR Tokyo Valves 2021

Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...

Tailoring mitral repair

Why durability matters: lifetime management considerations for supra-annular TAVR

26 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...

Why durability matters: lifetime management considerations for supra-annular TAVR

Cases on valvular disease

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover various interesting cases on valvular disease, such as the implantation of a transcatheter aortic VIV for an acute AR in prior bio Bentall operation, the percutaneous pulmonic balloon valvuloplasty in a carcinoid pulmonic stenosis, as well as the percutaneous valve-in-valve in the...

Cases on valvular disease

OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

08 Nov 2022

Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.

Ali Nazmi Calik

Author

Ali Nazmi Calik
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART
Didn’t find what you were looking for?